Muscle pain in myophosphorylase deficiency (McArdle's disease): The role of gender, genotype, and pain-related coping

Pain

Volumn 124, Issue 3, 2006, Pages 295-304

  Rommel, Oliver ^a,c   Kley, Rudolf A ^a   Dekomien, Gabriele ^b   Epplen, Jörg T ^b   Vorgerd, Matthias ^a   Hasenbring, Monika ^b  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c Rommel Klinik GMBH   (Germany)

Author keywords

Coping; Endurance; Genotype phenotype correlation; McArdle's disease; Pain

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADOLESCENT; ADULT; AGED; ARTICLE; AVOIDANCE BEHAVIOR; BECK DEPRESSION INVENTORY; CHRONIC PAIN; CLINICAL ARTICLE; CLINICAL FEATURE; COPING BEHAVIOR; CORRELATION ANALYSIS; DATA ANALYSIS; DISEASE DURATION; DISEASE SEVERITY; DISTRESS SYNDROME; ENDURANCE; EXERCISE; FEMALE; GENE MUTATION; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; GLYCOGEN STORAGE DISEASE TYPE 5; HEREDITY; HUMAN; MALE; MYALGIA; PAIN; PAIN PARAMETERS; PHENOTYPE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; QUESTIONNAIRE; RATING SCALE; RISK FACTOR; SEX DIFFERENCE; SLEEP; SOCIAL PSYCHOLOGY;

ADAPTATION, PSYCHOLOGICAL; ADOLESCENT; ADULT; AFFECTIVE SYMPTOMS; AGED; AGED, 80 AND OVER; EXERCISE; FEMALE; GENDER IDENTITY; GENOTYPE; GLYCOGEN PHOSPHORYLASE, MUSCLE FORM; GLYCOGEN STORAGE DISEASE TYPE V; HEALTH BEHAVIOR; HUMANS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; PAIN; PAIN MEASUREMENT; PHENOTYPE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION;

EID: 33748846248     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2006.04.017     Document Type: Article

References (48)

1. Bassez G., Attarian S., Laforet P., Azulay J.P., Rouche A., Ferrer X., et al. Proximal myotonic myopathy: clinical and histology study. Rev Neurol 157 (2001) 209-218
2. Beck A.T., Ward C.H., Mendelson M., Mock J., and Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 4 (1961) 561-571
3. Berger M., Gibbels E., Leven B., and Seiler M. McArdle's disease-description based on three own observations. Fortschr Neurol Psychiatr 46 (1978) 312-326
4. Berkley K.J. Sex differences in pain. Behav Brain Sci 20 (1997) 371-380
5. Buckelew S.P., Shutty M.S., Hewett J., Landon T., Morrow K., and Frank R.G. Health locus of control, gender differences and adjustment to persistent pain. Pain 42 (1990) 287-294
6. Bushby K.M.D., Pollitt C., Johnson M.A., Rogers M.T., and Chinnery P.F. Muscle pain as a prominent feature of facioscapulohumeral muscular dystrophy (FSHD): four illustrative case reports. Neuromusc Dis 8 (1998) 574-579
7. De Stefano N., Argov Z., Matthews P.M., Karpati G., and Arnold D.L. Impairment of muscle mitochondrial oxidative metabolism in McArdles's disease. Muscle Nerve 19 (1996) 764-769
8. Delorme T., Boureau F., Eymard B., Laforet P., and Cottrel F. Clinical study of chronic pain in hereditary myopathies. Eur J Pain 8 (2004) 55-61
9. DiMauro S., and Bresolin N. Phosphorylase deficiency. In: Engel A.G., and Franzini-Armstrong C. (Eds). Myology. 2nd ed. (1994), McGraw-Hill, New York 1585-1601
10. DiMauro S., Andreu A.L., Bruno C., and Hadjigeorgiou G. Myophosphorylase deficiency (glycogenosis Type V; McArdle disease). Curr Mol Med 2 (2002) 189-190
11. Fillingim R.B., and Maixner W. Gender differences in the responses to noxious stimuli. Pain Forum 4 (1995) 209-221
12. Fillingim R.B., and Ness T.J. Sex-related hormonal influences on pain and analgesic responses. Neurosci Biobehav Rev 24 (2000) 485-501
13. Grebner M., Breme K., Rothoerl R., Woertgen C., Hartmann A., and Thomé C. Coping und Genesungsverlauf nach lumbaler Bandscheibenoperation. Der Schmerz 13 (1999) 19-30
14. Griggs R.C., and Karpati G. Muscle pain, fatigue and mitochondriopathies. N Engl J Med 314 (1999) 1077-1078
15. Haller R.G., Wyrick P., Cavender D., Wall A., and Vissing J. Aerobic conditioning: an effective therapy in McArdle's disease. Neurology 50 (1998) A369
16. Haller R.G. Treatment of McArdle disease. Arch Neurol 57 (2000) 923-924
17. Hallner D., and Hasenbring M. Classification of psychosocial risk factors (yellow flags) for the development of chronic low back and leg pain using artificial neural network. Neurosci Lett 361 (2004) 151-154
18. Hasenbring M. Durchhaltestrategien- ein in der Schmerzforschung und - therapie vernachlässigtes Phänomen?. Der Schmerz 7 (1993) 304-313
19. Hasenbring M. Das Kieler Schmerz-Inventar. Manual (1994), Verlag Hans Huber, Bern, Switzerland
20. Hasenbring M., Marienfeld G., Kuhlendahl D., and Soyka D. Risk factors of chronicity in lumbar disc patients. Spine 19 (1994) 2759-2765
21. Hasenbring M., Ulrich H.W., Hartmann M., and Soyka D. The efficacy of a risk factor based cognitive behavioural intervention and EMG-biofeedback in patients with acute sciatic pain: an attempt to prevent chronicity. Spine 24 (1999) 2525-2535
22. Jensen I., Nygren A., Gamberale F., Goldie I., and Westerholm P. Coping with long-term musculoskeletal pain and its consequences: is gender a factor?. Pain 57 (1994) 167-172
23. Kammer D. Eine Untersuchung der psychometrischen Eigenschaften des deutschen Beck-Depressionsinventars (BDI). Diagnostica 29 (1983) 48-60
24. Keefe F.J., Abernethy A.P., and Campbell L. Psychological approaches to understanding and treating disease-related pain. Annu Rev Psychol 56 (2005) 601-630
25. Klasen B.W., Hallner D., Schaub C., Willburger R., and Hasenbring M. Validity and reliability of the German version of the Chronic Pain Grade questionnaire in primary care back patients. Psycho-Social-Med 1 (2004) Doc07
26. Kley R.A., Rommel O., Ricker K., Kress W., Malin J., and Vorgerd M. Myalgien bei proximaler myotoner Myopathie (PROMM). Aktuelle Neurologie 30 S1 (2003) S161
27. Martin R., and Connick E. Tension myalgia versus myoadenylate deaminase deficiency: case report. Arch Phys Med Rehabil 78 (1997) 95-97
28. Martin M.A., Rubio J.C., Buchbinder J., Fernandez-Hojas R., del Hoyo P., Teijeira S., et al. Molecular heterogeneity of myophosphorylase deficiency (McArdle's disease): a genotype-phenotype correlation study. Ann Neurol 50 (2001) 574-581
29. Martinuzzi A., Sartori E., Fanin M., Nascimbeni A., Valente L., Angelini C., et al. Phenotype modulators in myophosphorylase deficiency. Ann Neurol 53 (2003) 497-502
30. Mattle H., and Jerusalem F. Belastungsinduzierte Muskelschwäche, Myalgien und Kontrakturen. Schweiz Med Wschr 107 (1977) 428-436
31. McArdle B. Myopathy due to a defect in muscle glycogen breakdown. Clin Sci 24 (1951) 13-33
32. Mense S. Nociception from skeletal muscle in relation to clinical muscle pain. Pain 54 (1993) 241-289
33. Miller S.A., Dykes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16 (1988) 1215
34. Ollivier K., Hogrel J.Y., Gomez-Merino D., Romero N.B., Laforet P., Eymard B., et al. Exercise tolerance and daily life in McArdle's disease. Muscle Nerve 31 (2005) 637-641
35. Ricker K., Koch M.C., Lehmann-Horn F., Pongratz D., Speich N., Reiners K., et al. Proximal myotonic myopathy. Clinical features of a multisystem disorder similar to myotonic dystrophy. Arch Neurol 52 (1995) 25-31
36. Rigat B., Hubert C., Corvol P., and Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res 20 (1992) 1433
37. Riley III J.L., Robinson M.E., Wise E.A., Myers C.D., and Fillingim R.B. Sex-differences in the perception of noxious experimental stimuli: a meta-analysis. Pain 74 (1998) 181-187
38. Robinson M.E., Riley J.L., Brown F.F., and Gremillion H. Sex differences in response to cutaneous anaesthesia: a double blind randomized study. Pain 77 (1998) 143-149
39. Rommel O., Malin J.-P., Zenz M., and Jänig W. Quantitative sensory testing, neurophysiological and psychological examination in patients with complex regional pain syndrome and hemisensory deficits. Pain 93 (2001) 279-293
40. Ronnblom A., Forsberg H., and Danielsson N.A. Gastrointestinal symptoms in myotonic dystrophy. Scand J Gastroenterol 31 (1996) 654-657
41. Scholten-Peeters G.G., Verhagen A.P., Bekkering G.E., van der Windt D.A., Barnsley L., Oostendorp R.A., et al. Prognostic factors of whiplash-associated disorders: a systematic review of prospective cohort studies. Pain 104 (2003) 303-322
42. Smets E.M.A., Garssen B., Bonke B., and De Haes J.C.J.M. The multidimensional fatique inventory (MFI): psychometric qualities of an instrument to assess fatique. J Psychosom Res 39 (1995) 315-325
43. Turner J.A., and Romano J.M. Self-report screening measures for depression in chronic pain patients. J Clin Psychol 40 (1984) 909-913
44. Vlaeyen J.W.S., and Linton S.J. Fear-avoidance and its consequences in chronic musculoskeletal pain: a state of the art. Pain 85 (2000) 317-332
45. Von Korff M., Ormel J., Keefe F.J., and Dworkin S.F. Grading the severity of chronic pain. Pain 50 (1992) 133-149
46. Vorgerd M., Kubisch C., Burwinkel B., Reichmann H., Mortier W., Tettenborn B., Pongratz D., Lindemuth R., Tegenthoff M., Malin J.P., and Kilimann M.W. Mutation analysis in Myophosphorylase deficiency (McArdle's disease). Ann Neurol 43 (1998) 326-331
47. Wolfe G.I., Baker N.S., Haller R.G., Burns D.K., and Barohn R.J. McArdle's disease presenting with asymmetric, late-onset arm weakness. Muscle Nerve 23 (2000) 641-645
48. Zange J., Grehl T., Disselhorst-Klug C., Rau G., Muller K., Schroder R., et al. Breakdown of adenine nucleotide pool in fatiguing skeletal muscle in McArdle's disease: a noninvasive 31P-MRS and EMG study. Muscle Nerve 27 (2003) 728-736